New Pancreatic Cancer Drugs Double Survival Time

After 40 years without progress, researchers have developed drugs that are doubling survival times for pancreatic cancer patients.

One experimental treatment helped half of patients live beyond 13 months, compared to just over six months with standard chemotherapy.